NCT03624959View on ClinicalTrials.gov

Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A

PHASE1CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

August 10, 2018

Study Completion Date

August 10, 2018

Conditions

Healthy Volunteer

Interventions

DRUG

Ozanimod

ozanimod

DRUG

Gemfibrozil

Gemfibrozil

DRUG

Itraconazole

Itraconazole

DRUG

Rifampin

Rifampin

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY